GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Summit Therapeutics Inc (MEX:SMMT) » Definitions » E10

Summit Therapeutics (MEX:SMMT) E10 : MXN-12.54 (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Summit Therapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Summit Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2024 was MXN-1.877. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN-12.54 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was 10.00% per year. During the past 5 years, the average E10 Growth Rate was 4.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Summit Therapeutics was 10.00% per year. The lowest was -0.80% per year. And the median was 2.20% per year.

As of today (2025-03-24), Summit Therapeutics's current stock price is MXN425.32. Summit Therapeutics's E10 for the quarter that ended in Dec. 2024 was MXN-12.54. Summit Therapeutics's Shiller PE Ratio of today is .


Summit Therapeutics E10 Historical Data

The historical data trend for Summit Therapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Summit Therapeutics E10 Chart

Summit Therapeutics Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -12.54

Summit Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -12.54

Competitive Comparison of Summit Therapeutics's E10

For the Biotechnology subindustry, Summit Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Summit Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Summit Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Summit Therapeutics's Shiller PE Ratio falls into.



Summit Therapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Summit Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-1.877/133.1571*133.1571
=-1.877

Current CPI (Dec. 2024) = 133.1571.

Summit Therapeutics Quarterly Data

per share eps CPI Adj_EPS
201501 -1.583 98.604 -2.138
201504 -1.424 99.824 -1.900
201507 -1.754 100.691 -2.320
201510 -2.295 100.346 -3.045
201601 -2.075 99.957 -2.764
201604 -2.261 100.947 -2.982
201607 -2.479 101.524 -3.251
201610 -1.836 101.988 -2.397
201701 -2.083 102.456 -2.707
201704 -1.959 103.167 -2.528
201707 -1.174 103.278 -1.514
201710 -0.253 104.070 -0.324
201801 -4.217 104.578 -5.369
201804 -2.068 105.708 -2.605
201807 7.817 106.324 9.790
201810 -2.574 106.695 -3.212
201901 -1.249 106.200 -1.566
201904 -0.737 107.818 -0.910
201907 -0.693 108.250 -0.852
201910 -0.989 108.577 -1.213
202003 -2.140 108.902 -2.617
202006 -5.309 108.767 -6.499
202009 -5.744 109.815 -6.965
202012 -3.581 109.897 -4.339
202103 -4.293 111.754 -5.115
202106 -5.375 114.631 -6.244
202109 -4.112 115.734 -4.731
202112 -5.744 117.630 -6.502
202203 -2.987 121.301 -3.279
202206 -2.414 125.017 -2.571
202209 -2.011 125.227 -2.138
202212 -0.780 125.222 -0.829
202303 -25.776 127.348 -26.952
202306 -0.343 128.729 -0.355
202309 -0.523 129.860 -0.536
202312 -0.170 129.419 -0.175
202403 -0.996 131.776 -1.006
202406 -1.649 132.554 -1.657
202409 -1.575 133.029 -1.577
202412 -1.877 133.157 -1.877

Add all the adjusted EPS together and divide 10 will get our e10.


Summit Therapeutics  (MEX:SMMT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Summit Therapeutics E10 Related Terms

Thank you for viewing the detailed overview of Summit Therapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Summit Therapeutics Business Description

Traded in Other Exchanges
Address
601 Brickell Key Drive, Suite 1000, Miami, FL, USA, 33131
Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.